BSEMitsu Chem Plast LtdMediumNeutral
Announced Fri, 8 May · 18:40 IST

Earnings Call Transcript for Q4FY26

Mgmt Guided Margin ImprovementOrder Pipeline DisclosedAnalyst Day Multiyear TargetsInvestor Communications View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-9.0%1-day move
₹170.65
prior close
₹175.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.0-4.6-5.0-5.1-9.0-11.4-15.9-11.7-15.0-15.6-13.9-15.0-17.4
Up moveDown movePending
AI summary

Mitsu Chem Plast reported Q4 FY26 total income of INR86.79 crore with EBITDA of INR14.23 crore (margin 16.45%) and net profit of INR7.72 crore, up 117.90% YoY. Full-year FY26 revenue was INR350.85 crore (up 5.4% YoY), with EBITDA margin expanding 289 bps to 9.90%. Management attributed Q4 margin strength partly to raw material pricing benefits from the geopolitical situation (1-2% impact) and value-added product mix, with HDPE raw material costs up ~40% year-on-year in Q4. The company announced a new IBC (Intermediate Bulk Container) vertical at its Khalapur facility, targeting Q2 launch. Furnastra healthcare furniture currently contributes ~16% of revenue at 15%+ EBITDA margins, vs ~84% from packaging containers. The company guided for 30% revenue growth in FY27, concentrated in the second half, and reaffirmed its INR1,000 crore revenue target by FY28.

Likely market impact

Strong bottom-line recovery with 117% net profit growth and margin expansion to double digits signals operational turnaround, though Q4 margins were inflated by one-off raw material tailwinds. The new IBC vertical and Furnastra healthcare furniture expansion represent meaningful future growth drivers, but the company's deliberate focus on profitability over top-line growth means revenue acceleration will be back-loaded to H2 FY27.